Utah Medical Products Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	37.53	38.52	40.9	50.22	52.28	49.05
Revenue Growth (YoY)	-4.43%	-5.83%	-18.56%	-3.94%	6.58%	16.30%
Cost of Revenue	15.79	16.52	16.76	20.19	20.09	18.14
Gross Profit	21.75	22	24.14	30.04	32.2	30.92
Selling, General & Admin	4.48	9.93	9.74	12.7	11.91	11.51
Research & Development	0.67	0.67	0.81	0.56	0.49	0.53
Total Operating Expenses	5.15	10.6	10.55	13.26	12.41	12.04
Operating Income	10.81	11.4	13.59	16.78	19.79	18.88
Interest Income	-	2.83	3.38	3.06	0.68	0.18
Other Non-Operating Income (Expense)	-	-0.12	-0.17	0.26	0.19	-
Total Non-Operating Income (Expense)	1.96	2.71	3.21	3.31	0.87	0.18
Pretax Income	13.43	14.11	16.8	20.09	20.66	19.06
Provision for Income Taxes	2.58	2.82	2.93	3.45	4.19	4.27
Net Income	5.68	11.29	13.87	16.64	16.47	14.79
Net Income to Common	5.68	11.29	13.87	16.64	16.47	14.79
Net Income Growth	-19.06%	-18.65%	-16.60%	0.98%	11.39%	36.95%
Shares Outstanding (Basic)	3	3	4	4	4	4
Shares Outstanding (Diluted)	3	3	4	4	4	4
Shares Change (YoY)	-6.36%	-7.51%	-3.68%	-0.17%	-0.46%	-0.33%
EPS (Basic)	3.38	3.48	3.96	4.58	4.53	4.05
EPS (Diluted)	3.38	3.48	3.96	4.57	4.52	4.04
EPS Growth	-10.46%	-12.12%	-13.35%	1.11%	11.88%	37.41%
Shares Outstanding	3.18	3.19	3.34	3.63	3.63	3.65
Free Cash Flow	13.02	14.32	14.6	21.64	20.34	20.65
Free Cash Flow Growth	-9.09%	-1.92%	-32.53%	6.41%	-1.52%	7.13%
Free Cash Flow Per Share	4.06	4.42	4.17	5.95	5.58	5.64
Dividends Per Share	1.230	1.225	1.205	1.185	1.165	0.855
Dividend Growth	0.41%	1.66%	1.69%	1.72%	36.26%	-23.66%
Gross Margin	57.94%	57.12%	59.03%	59.81%	61.58%	63.03%
Operating Margin	28.81%	29.60%	33.23%	33.40%	37.85%	38.49%
Profit Margin	15.13%	29.30%	33.92%	33.12%	31.51%	30.15%
FCF Margin	34.69%	37.18%	35.70%	43.09%	38.90%	42.10%
EBITDA	13.79	14.41	16.44	23.15	26.87	26.16
EBITDA Margin	36.74%	37.41%	40.19%	46.08%	51.40%	53.34%
EBIT	10.81	11.4	13.59	16.78	19.79	18.88
EBIT Margin	28.81%	29.60%	33.23%	33.40%	37.85%	38.49%
Effective Tax Rate	19.24%	20.01%	17.43%	17.19%	20.26%	22.42%

Updated May 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q